Business · 09/05/2007
FDA Publishes Guidance for Gene Expression Profiling Test Systems for Breast Cancer Prognosis
The FDA has released a guidance document outlining the requirements for gene expression profiling test systems used to predict breast cancer prognosis, which will take effect immediately and is open to public comment.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →